Immunai is on a mission to decode the immune system to improve health by comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.

FUND I / ACTIVE

Immunai aims to transform immune biomarkers and pathway discovery, starting with cancer. They collect peripheral tissues and generate a comprehensive, high-integrity, data set to capture the most granular patient immune-fingerprint.

FUND I / ACTIVE